A Cambridge error correction firm opened a US headquarters this week and an Icelandic acoustics platform raised money to expand west. European capability keeps drifting towards American demand.
The counterweight came from public budgets. The Netherlands funded an agency rather than a budget line, ESA signed eighty companies to study the next secure constellation, and Galileo proved a service no rival system offers for free.
Lead
The Netherlands Builds Its Own DARPA and Funds It
The Dutch cabinet proposed an innovation package on 17 September: EUR 500 million for a National Agency for Disruptive Innovation, EUR 333 million to restart the National Growth Fund through 2031, and EUR 3.5 billion for a public investment institution covering AI, security, climate technology, and life sciences.
NADI comes out of former ASML chief executive Peter Wennink's competitiveness report and is modelled on DARPA. It will fund consortia of companies, startups, and universities, and Jelle Prins, who founded the protein design firm Cradle, is expected to lead it.
Most European competitiveness money arrives as a line inside a ministry, where the next budget cycle can quietly shrink it. This arrives as an agency with its own mandate and its own balance sheet.
Biotech & Life Sciences
Novo Nordisk Licenses a Copenhagen Platform Instead of Buying It
Orbis Medicines signed a multi-target discovery and licence agreement with Novo Nordisk on 17 September worth up to USD 1.4 billion in upfront and milestone payments, plus royalties and a strategic equity stake.
Orbis builds synthetic macrocycles it calls nCycles, engineered for the oral bioavailability that has kept this class of molecule out of pill form. The target is cardiometabolic disease, where Novo already knows what an oral version is worth.
Both sides of this deal sit in Copenhagen, and the platform stays with the smaller one.
(BioSpace)
BioNTech Shows What the Vaccine Money Bought
At the World Conference on Lung Cancer in Seoul, BioNTech reported Phase III data for gotistobart in previously treated squamous non-small-cell lung cancer: median overall survival of 18.5 months, against 10.0 for docetaxel.
A single-arm mesothelioma cohort of 31 patients on pumitamig reached median progression-free survival of 16.6 months. Combined with the antibody-drug conjugate elfetabart drozuntecan, pumitamig produced a 92 per cent response rate in first-line small-cell lung cancer.
Small cohorts are signals, not registrational evidence. What they show is a Mainz company that converted a vaccine windfall into sixteen lung cancer trials, five of them Phase III.
Quantum & Photonics
Riverlane Moves Its Error Correction Hiring to Maryland
Riverlane announced a US headquarters and error correction research hub on 17 September, in the Discovery District beside the University of Maryland and the UMD-NIST joint quantum centre. It is hiring there across research, engineering, and commercial roles.
Error correction is the layer every hardware vendor needs and few can build alone, which is why Riverlane already works with IQM and Quantum Motion. Cambridge built that position; the hiring for it now happens where the defence budgets are.
Space
Galileo Holds a Fix While Being Spoofed
ESA and the Commission's Joint Research Centre obtained the first civil authenticated position fix under live spoofing at Jammertest in Norway, where the authorities broadcast interference scenarios each September.
The Signal Authentication Service encrypts the ranging signals; OSNMA, operational since 2025, authenticates the navigation message. Together they let a receiver reject a forged signal rather than trust it.
EUSPA runs accreditation next year, and both services will be free worldwide. Spoofing is routine across the Baltic and the Black Sea, and no rival constellation offers mass-market authentication.
(ESA)
Materials & Manufacturing
ETH Zurich Makes OLEDs a Lithography Problem
A team led from ETH Zurich with the University of Helsinki published electroluminescent photoresists in Nature on 16 September. The polymers are star-shaped, with a core-shell architecture keeping the light-emitting cores away from the reactive crosslinking groups at the surface.
That separation is what lets the material survive patterning. The group demonstrated lithography down to 110 nanometre features and multicolour OLEDs above 13 per cent external quantum efficiency.
Organic displays are made by vacuum evaporation or inkjet printing, neither of which talks to CMOS lithography, so monolithic integration has never happened. Turning emitters into a photoresist moves the problem into the discipline European tooling already leads.
(Nature)
Robotics & Automation
Treble Raises EUR 15 Million to Give Robots Ears
Treble, founded in Reykjavik in 2020 by the acoustic engineers Finnur Pind and Jesper Pedersen, raised roughly EUR 15 million in a Series A-2 led by Paladin Capital Group, with the European Innovation Council Fund taking part.
The platform simulates the acoustic physics of real rooms in the cloud, producing digital twins and labelled synthetic audio for training. Amazon and Logitech use it to skip physical prototypes.
Machines working near people have to separate a voice from a factory floor, and gathering that data in the real world is slow enough that the simulator becomes the product. The new money goes to physical AI and US expansion.
Semiconductors
Tusk IC Raises EUR 15 Million for the Boring Part
Tusk IC, a KU Leuven spin-off in Antwerp now run by former imec Netherlands director Kathleen Philips, closed a EUR 15 million Series A on 17 September led by Matterwave Ventures and Forward.one, with the Flanders Future Tech Fund participating.
It builds Ka-band beamformer chips in standard CMOS, which let a flat panel antenna steer electronically instead of pointing a dish. It won an ESA Artes contract earlier this year with Belgian federal support.
The money is for volume production: robustness tuning, quality assurance, test programmes, and back-end assembly. European chip startups usually have the design and stall at exactly this step.
One to Watch
Eighty Companies Start Sketching the Next IRIS²
ESA signed 18 consolidation contracts covering nearly 80 companies on 17 September to study secure connectivity services and mission concepts under its Low-LEO activities.
Low-LEO validates candidate government services in orbit before any of them enter the IRIS² baseline, the constellation Poland nearly doubled its commitment to in July.
Watch which of the 18 studies reach a flight demonstration, and which survive the programme decisions after that. The structure deliberately admits smaller suppliers, so it also tests whether ESA can widen a strategic constellation's industrial base rather than narrow it to the usual primes.
(ESA)